Basic Information
ID: ALA4012620
Type: Binding
Description: Inhibition of VEGFR2 (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition in presence of ATP by mobility shift assay
Organism: Homo sapiens
Activity Charts
Bioactivity
Activity Types for Assay ALA4012620
IC50
Compound Summary
| Parent Molecular Weight | ALogP | Polar Surface Area |
|---|---|---|
| 493.62 | 4.59 | 4.59 |
| 375.41 | 4.90 | 4.90 |
| 387.44 | 4.32 | 4.32 |
| 357.42 | 4.89 | 4.89 |
| 441.54 | 4.33 | 4.33 |
| 383.46 | 4.22 | 4.22 |
| 337.43 | 4.25 | 4.25 |
| 375.43 | 4.79 | 4.79 |
| 386.46 | 4.64 | 4.64 |
| 411.39 | 5.60 | 5.60 |
| 323.40 | 3.85 | 3.85 |
| 455.57 | 4.64 | 4.64 |
| 361.38 | 4.72 | 4.72 |
| 309.37 | 3.46 | 3.46 |
| 393.45 | 5.73 | 5.73 |
| 363.45 | 4.32 | 4.32 |
| 442.52 | 4.72 | 4.72 |
| 414.51 | 5.42 | 5.42 |
| 371.44 | 5.14 | 5.14 |
| 375.41 | 5.02 | 5.02 |
| 399.50 | 5.08 | 5.08 |
| 351.45 | 4.64 | 4.64 |
| 393.42 | 4.93 | 4.93 |
| 347.38 | 3.85 | 3.85 |
| 422.29 | 5.34 | 5.34 |
| 368.40 | 4.45 | 4.45 |
| 425.41 | 5.85 | 5.85 |
| 373.42 | 4.07 | 4.07 |
| 442.52 | 4.72 | 4.72 |
| 386.46 | 4.64 | 4.64 |
| 333.36 | 3.30 | 3.30 |
| 323.40 | 3.85 | 3.85 |
| 344.38 | 3.97 | 3.97 |
| 335.41 | 4.00 | 4.00 |
| 438.35 | 5.50 | 5.50 |
| 455.57 | 4.64 | 4.64 |
| 357.42 | 4.89 | 4.89 |
| 391.41 | 4.73 | 4.73 |
| 394.44 | 5.13 | 5.13 |
| 414.51 | 5.42 | 5.42 |
| 358.41 | 3.65 | 3.65 |
| 357.42 | 4.26 | 4.26 |
| 307.36 | 3.22 | 3.22 |
| 349.44 | 4.39 | 4.39 |
| 377.83 | 5.23 | 5.23 |
| 295.35 | 3.07 | 3.07 |
| 455.57 | 4.64 | 4.64 |
| 393.45 | 5.73 | 5.73 |
| 428.50 | 4.41 | 4.41 |
| 371.44 | 4.30 | 4.30 |
| 373.42 | 4.59 | 4.59 |
| 385.47 | 4.69 | 4.69 |
| 323.40 | 3.71 | 3.71 |
| 427.46 | 5.76 | 5.76 |
| 411.39 | 5.60 | 5.60 |
| 400.49 | 4.64 | 4.64 |
| 357.42 | 4.89 | 4.89 |
| 344.38 | 3.97 | 3.97 |
| 321.38 | 3.61 | 3.61 |
| 441.54 | 4.33 | 4.33 |